ClinicalTrials.gov
ClinicalTrials.gov Menu

Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke (NETs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02476188
Recruitment Status : Completed
First Posted : June 19, 2015
Last Update Posted : October 20, 2017
Sponsor:
Collaborators:
Institut National de la Santé Et de la Recherche Médicale, France
University of Paris 5 - Rene Descartes
Information provided by (Responsible Party):
Centre Hospitalier St Anne

Brief Summary:
The purpose of the study was to investigate the correlation between the nucleosome concentration and the rate of recanalization after thrombolysis. All patients were admitted to the Stroke Unit at the University Hospital Sainte-Anne where they received standard stroke care. The investigators included all patients treated or not by intravenous thrombolysis for anterior circulation stroke with or without vessel occlusion. Exclusion criteria were neoplasms, chronic inflammatory diseases and cytostatic therapy at the time of stroke and stroke-specifics symptoms that had started earlier than 4.5 hours before admission.

Condition or disease Intervention/treatment Phase
Acute Stroke Procedure: Sample of Blood Not Applicable

Detailed Description:

Neutrophil extracellular traps (NETs) were measured in serum at the time of hospitalization, then at 4 hours, 24 hours and 72 hours after stroke. Because of nucleosome instability, a strict preanalytical protocol was followed. Blood samples were centrifuged within 1-2 h after blood drawing. A strict preanalytical protocol was followed including early centrifugation of the samples and storage at - 80°C. NETs were quantified in batches containing all samples from a patient using the detection of MPO (myeloperoxidase) then the Cell-Death-Detection ELISAPLUS (Roche Diagnostics, Germany) as described earlier. Nucleosomes were quantified in relative arbitrary units (AU). Blood samples from each patient were measured within the same run to improve the comparability of the results.

For statistical analysis, various variables of nucleosomes were considered, such as the absolute concentrations determined at admission, at 24 hours and at 72 hours after stroke. Influence of nucleosome concentration on recanalization was tested. Continuous correlations of nucleosomes and infarction volume, nucleosomes and clot size, as well as of infarction volume and NIHSS were calculated by Spearman's rank correlation together with the 95% confidence interval. A p value < 0.05 was considered statistically significant.

The extent of the morphological damage was determined at time of admission to the hospital and 24 hours after thrombolysis by diffusion-weighted magnetic resonance imaging (MRI). The pretreat¬ment and follow-up DWI lesions was segmented using interactive tools based on DWI signal intensity thresholding within a 3-dimensional mask encompassing the apparent area of bright DWI signal intensity and morphometric filtering. The clot location and length were assessed on the susceptibility vessel sign on T2* as describe earlier.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 124 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Neutrophil Extracellular Traps and Thrombolysis in the Acute Stroke
Actual Study Start Date : July 31, 2015
Actual Primary Completion Date : August 2016
Actual Study Completion Date : November 2016

Arm Intervention/treatment
Experimental: Patients
Samples of blood at H0, H+6, H+24 and H+72
Procedure: Sample of Blood
Experimental: Patients control
Samples of blood at H0
Procedure: Sample of Blood
Active Comparator: Control (healthy person)
Samples of blood at H0
Procedure: Sample of Blood



Primary Outcome Measures :
  1. Rate of recanalisation [ Time Frame: 24 hours ]
    Correlation between NETs and stroke severity


Secondary Outcome Measures :
  1. Thrombus size on MRI [ Time Frame: 24 hours ]
    Correlation between NETs and stroke severity

  2. Stroke volume on MRI [ Time Frame: 24 hours ]
    Correlation between NETs and stroke severity



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Patients ("Patients" + "Patients control" groups) :

Inclusion-1st sample of blood : every patient recruited within the neurovascular unit of intensive care of the Hospital center Sainte - Anne within the framework of a "thrombolyse alert ".

Then pursuit of the study ("patients" group only) if :

  • Age 18 minimum
  • Sylvien Infarct proved by the intellectual MRI,
  • Whatever is the treatment received (Aspegic, thombolysis and/or thrombectomy)
  • That there is occlusion of a cerebral artery or not "Controls" group :
  • Healthy subjects,
  • Mated on the age and the vascular risk factors (tobacco, arterial high blood pressure, diabetes and dyslipidémie)

Exclusion Criteria:

  • Patients:
  • Contraindications in the intravenous thrombolysis according to the current recommendations .

    • Controls:
  • Histories of evolutionary pathology or thrombo-embolique, taken by treatment whatever it is except contraceptive for the women, the viral or bacterial infection in the month precedents

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02476188


Locations
France
Centre Hospitalier Sainte-Anne
Paris, France, 75014
Sponsors and Collaborators
Centre Hospitalier St Anne
Institut National de la Santé Et de la Recherche Médicale, France
University of Paris 5 - Rene Descartes
Investigators
Study Director: Michel PLOTKINE, PhD University of Paris 5 - Rene Descartes